Search

Baxter International Inc

Закрыт

СекторЗдравоохранение

26.72 -1.44

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

26.58

Макс.

27.09

Ключевые показатели

By Trading Economics

Доход

141M

126M

Продажи

259M

3B

Прибыль на акцию

0.56

Дивидендная доходность

0.73

Рентабельность продаж

4.257

Сотрудники

37,500

EBITDA

177M

474M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

-3.11% downside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

0.73%

2.22%

Следующий отчет о доходах

29 окт. 2026 г.

Дата следующей выплаты дивидендов

1 окт. 2026 г.

Следующая эксдивидендная дата

28 авг. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

2.3B

14B

Предыдущая цена открытия

28.16

Предыдущая цена закрытия

26.72

Новостные настроения

By Acuity

29%

71%

104 / 340 Рейтинг в Healthcare

Baxter International Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

13 авг. 2026 г., 19:46 UTC

News

Baxter International recalls Duo-Vent Solution Set lots due to air bubble risks. Shares are trading higher since Wednesday's close despite the recall announcement.

12 авг. 2026 г., 23:46 UTC

Baxter International Inc shares are higher in after-market trading, supported by recent inflation data that may influence Federal Reserve interest rate decisions.

11 авг. 2026 г., 23:06 UTC

Baxter International Inc. shares traded roughly flat in after-market hours, reflecting a minor decline from earlier highs amid strong gains over the past month.

10 авг. 2026 г., 23:16 UTC

Baxter International Inc shares are lower in after-market trading. No specific news was identified to explain this movement amid rising U.S. Treasury yields.

7 авг. 2026 г., 23:51 UTC

Baxter International Inc shares are lower in after-market hours, retracing from earlier gains amid broader market sentiment influenced by a declining unemployment rate.

6 авг. 2026 г., 19:36 UTC

Baxter International Inc. shares are lower today, with no specific news identified to explain the movement. The stock remains near its one-month range.

5 авг. 2026 г., 20:01 UTC

Baxter International Inc shares are lower today, continuing a downward trend. The stock remains above its 20-day moving average despite recent declines.

4 авг. 2026 г., 22:51 UTC

News

Baxter International shares are lower in after-market hours following the announcement of Interim CFO Anita Zielinski's resignation, effective September 15, 2026.

3 авг. 2026 г., 23:02 UTC

Baxter International Inc shares are trading lower in after-market hours. Broader market volatility contributed to this decline without any specific company news.

31 июл. 2026 г., 23:46 UTC

Baxter International shares are lower in after-market trading, following a brief session rise. Rising U.S. Treasury yields and crude oil prices heighten inflation concerns.

30 июл. 2026 г., 23:21 UTC

Baxter International Inc shares are lower in after-market trading, reflecting unusual volatility despite strong performance over the past month.

29 июл. 2026 г., 22:02 UTC

Baxter International Inc. shares are lower in after-market trading, mirroring the broader market's decline amid geopolitical tensions and inflation concerns.

28 июл. 2026 г., 22:41 UTC

Baxter International Inc shares rose in after-market trading, continuing a trend of higher daily closes and remaining above the 20-day moving average.

27 июл. 2026 г., 19:21 UTC

News

Baxter International shares are higher as TD Cowen raises the price target to $24.00, reflecting positive sentiment in the Health Care Equipment sector.

24 июл. 2026 г., 19:02 UTC

Baxter International Inc shares are higher, reflecting market response to a decline in crude oil prices that eased inflationary pressures.

22 июл. 2026 г., 19:56 UTC

News

Baxter International faces scrutiny over weak growth and declining earnings, contributing to lower shares amid broader weakness in the Health Care Equipment sector.

21 июл. 2026 г., 23:01 UTC

Baxter International Inc. shares declined in after-hours trading, reflecting a weak performance despite a slight recovery from earlier session lows.

20 июл. 2026 г., 23:02 UTC

Baxter International Inc shares are higher in after-market trading, reaching 1.27% above Monday's close and near the upper end of their one-month range.

Сравнение c конкурентами

Изменение цены

Baxter International Inc Прогноз

Целевая цена

By TipRanks

-3.11% падение

Прогноз на 12 месяцев

Средняя 25.9 USD  -3.11%

Максимум 29 USD

Минимум 21 USD

Основано на мнении 10 аналитиков Wall Street, спрогнозировавших целевые цены для Baxter International Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

10 ratings

1

Покупка

9

Удержание

0

Продажа

Настроения

By Acuity

104 / 340Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
help-icon Live chat